ABHD11 Inhibition Reduces T-Cell Activity in Autoimmune Conditions
A new study led by Swansea University has revealed a potential treatment for certain autoimmune diseases by targeting a protein that regulates energy production in immune cells.
Autoimmune diseases, such as rheumatoid arthritis or type 1 diabetes, are driven by immune cells called T-cells. Normally, T-cells protect the body from infections, but in autoimmunity, they mistakenly attack the body’s own tissues.
A new way to potentially treat certain autoimmune diseases by targeting a protein that helps regulate energy production in immune cells.
Author's summary: Researchers found a new way to treat autoimmune diseases.
- Rheumatoid arthritis
- Type 1 diabetes